Skip to content

AIDS Research at the NIH: A Critical Review Part I: Summary

Publication • 1992
By Gregg Gonsalves and Mark Harrington VIII International Conference on AIDS, Amsterdam, the Netherlands, July 20, 1992 From the Introduction Since 1987, the activist critique of AIDS research has worked its way back: from drug approval at the regulatory level of the US Food + Drug Administration (FDA), to expanded access for drugs still under…

False Hope: Congress Failed to Protect Your Right to Safe, Effective Medicines

Statement / Press
On May 30, 2018, President Trump signed β€œTrickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, or S.204,” into law, after the House followed the Senate in caving to libertarian de-regulation pressure. The new law creates a second pathway for pre-approval access, redundant given the Food and Drug Administration…

A Lower Price for Rifapentine Is Just a Start – Communities Need More Than Discounts to Access TB Preventive Therapy

Statement / Press
Civil society and community-based organizations issued this statement welcoming the availability of lower-priced rifapentine, which is an essential medicine for preventing TB.

Research in Action Awards 2020

Please join us at our annual, and first ever virtual, Research in Action Awards on Thursday, November 19, 2020. At this time of great turmoil and when activism to end infectious disease is more vital than ever, it’s so important to gather virtually to celebrate life, commemorate those we’ve lost, and recognize champions of progress and justice.

MSF Commitments for β€œ1/4/6 x 24” Campaign Launch in October

After half a century of stagnant progress, tuberculosis (TB) treatment has made significant advancements in the last 10 years. Research and development have resulted in new internationally recognised drugs and shorter, safer, and more effective regimens for the treatment of latent, drug-susceptible (DS-TB) and drug-resistant TB (DR-TB). However, progress on implementation has lagged behind the…

Make a Gift of Stock: Unlock the Power of Your Investments

By making a gift of stock to Treatment Action Group (TAG), you have the opportunity to support our life-saving work while also receiving valuable benefits for yourself. Whether you purchased the stock at a lower price or it has appreciated in value, contributing stocks can have a significant impact on both TAG’s mission and your…

RIAA Honoree, Mercedes C. Becerra, ScD


Global Fund Against HIV, TB, and Malaria Pledge for the 1/4/6×24 Campaign

Eliud Wandwalo, Global Fund Against HIV, TB, and Malaria I would like to take this opportunity to congratulate TAG and all the partners for this incredible initiative. We are very proud as Global Fund to be part of it. This is aligning very much with our new strategy, which was approved last yearβ€”it’s an extremely…

Limited Art Edition 2022

2022 TAG Limited Art Edition To purchase this unique work, please use this form. The 2022 TAG Limited Art Edition was supported by a generous grant from the Marta Heflin Foundation.   Rafael SΓ‘nchez Tintura del Sol 2022 Archival pigment print + wood frame 17 x 11 inches (print) 21 x 15 x 1.5 inches…

Story: HIV Short Film, β€œRight To Try”

December 2021 Update, June 2022: The purported researcher responsible for the experiment described in this film, Serhat Gumrukcu, was indicted for murder-for-hire at the end of May 2022. The case is ongoing. In parallel, two independent investigations by financial media outlets (Hindenburg Research and Sharesleuth) have presented extremely disturbing findings about Gumrukcu’s past and were…
Back To Top